The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Bacterial protease inhibitors
Abstract
Serine‐, cysteine‐, and metalloproteases are widely spread in many pathogenic bacteria, where they play critical functions related to colonization and evasion of host immune defenses, acquisition of nutrients for growth and proliferation, facilitation of dissemination, or tissue damage during infection. Since all the antibiotics used clinically at the moment share a common mechanism of action, acting as inhibitors of the bacterial cell wall biosynthesis or affecting protein synthesis on ribosomes, resistance to these pharmacological agents represents a serious medical problem, which might be resolved by using new generation of antibiotics, possessing a different mechanism of action. Bacterial protease inhibitors constitute an interesting such possibility, due to the fact that many specific as well as ubiquitous proteases have recently been characterized in some detail in both gram‐positive as well as gram‐negative pathogens. Few potent, specific inhibitors for such bacterial proteases have been reported at this moment except for some signal peptidase, clostripain, Clostridium histolyticum collagenase, botulinum neurotoxin, and tetanus neurotoxin inhibitors. No inhibitors of the critically important and ubiquitous AAA proteases, degP or sortase have been reported, although such compounds would presumably constitute a new class of highly effective antibiotics. This review presents the state of the art in the design of such enzyme inhibitors with potential therapeutic applications, as well as recent advances in the use of some of these proteases in therapy. © 2002 Wiley Periodicals, Inc. Med Res Rev, 22, No. 4, 329–372, 2002; Published online in Wiley InterScience (www.interscience.wiley.com). DOI 10.1002/med.10007
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staphylococcus aureus Sortase, an Enzyme that Anchors Surface Proteins to the Cell Wall
Mazmanian, S. K., Liu, G., Ton-That, H., & Schneewind, O. (1999) · Science · doi:10.1126/science.285.5428.760 · Cited by 1,053
Ton-That, H., Liu, G., Mazmanian, S. K., Faull, K. F., & Schneewind, O. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12424 · Cited by 567
Anchoring of Surface Proteins to the Cell Wall of Staphylococcus aureus
Ton-That, H., Mazmanian, S. K., Faull, K. F., & Schneewind, O. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.13.9876 · Cited by 359
Sortase, a universal target for therapeutic agents against Gram-positive bacteria?
Cossart, P., & Jonquières, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5013 · Cited by 203
Cited by
Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases
Powers, J. C., Asgian, J. L., Ekici, Ö. D., & James, K. E. (2002) · Chemical Reviews · doi:10.1021/cr010182v · Cited by 1,090
Proteases and Delayed Wound Healing
McCarty, S. M., & Percival, S. L. (2013) · Advances in Wound Care · doi:10.1089/wound.2012.0370 · Cited by 476
Protease inhibitors of the sulfonamide type: Anticancer, antiinflammatory, and antiviral agents
Supuran, C. T., Casini, A., & Scozzafava, A. (2003) · Medicinal Research Reviews · doi:10.1002/med.10047 · Cited by 431
Self-citationPlant protease inhibitors: a defense strategy in plants
(2007) · Biotechnology and Molecular Biology Reviews · doi:10.5897/bmbr2007.0006 · Cited by 292
McCarty, S. M., Cochrane, C. A., Clegg, P. D., & Percival, S. L. (2012) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2012.00763.x · Cited by 193
Metadata
- Authors
- Supuran, C. T., Scozzafava, A., & Clare, B. W.
- Venue
- Medicinal Research Reviews
- Publisher
- Wiley
- Published
- 2002-06-06
- Volume
- 22
- Issue
- 4
- Pages
- 329-372
- ISSN
- 0198-6325 (ISSN-L)
- 1098-1128
- OpenAlex
- W1968567870
- Cited by
- 172
- References
- 4
- FWCI
- 2.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bacterial protease inhibitors. https://app.cochat.ai/papers/10.1002/med.10007
- The paper
- Supuran, C. T., Scozzafava, A., & Clare, B. W. (2002). Bacterial protease inhibitors. Medicinal Research Reviews. https://doi.org/10.1002/med.10007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.